Allergan, Inc. News Headlines

AGN 
$234.4299
*  
1.6899
0.73%
Get AGN Alerts
*Delayed - data as of Mar. 2, 2015 12:14 ET  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    AGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Farallon Capital raises stake in Allergan
1/14/2015 12:00:00 PM - Market Realist


Farallon Capital ups stake in Covidien
1/14/2015 10:00:00 AM - Market Realist


Farallon Capital increases stake in DIRECTV
1/14/2015 8:00:00 AM - Market Realist


Roche to Acquire Up to 56% Interest in Foundation Medicine - Analyst Blog
1/14/2015 6:20:00 AM - Investopedia


Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog
1/14/2015 5:35:00 AM - Investopedia


Farallon Capital starts new position in Cognizant Tech Solutions
1/13/2015 4:00:00 PM - Market Realist


Farallon Capital starts new position in Time Warner Inc.
1/13/2015 10:00:00 AM - Market Realist


Actavis' Q4 Earnings to Beat Expectations, Growth Continues - Analyst Blog
1/13/2015 4:00:00 AM - Investopedia


Digging Deeper: Outperforming Stocks In The Leading Health Care Sector
1/12/2015 12:10:00 PM - Seeking Alpha


Actavis Expects Profit to Beat Expectations
1/12/2015 9:36:00 AM - Dow Jones Business News


Comparing America's 3 Largest Drug Manufacturers/Other Companies
1/12/2015 9:20:00 AM - Seeking Alpha


Actavis-Allergan Deal Gets U.S. Antitrust Approval - Quick Facts
1/12/2015 8:12:00 AM - RTT News


Novartis Submits NDA for Ultibro & Seebri Breezhaler - Analyst Blog
1/12/2015 5:30:00 AM - Investopedia


Cramer's Mad Money - Top 10 Performers Of The S&P 500 For 2014 (1/8/15)
1/9/2015 5:33:00 AM - Seeking Alpha


Novartis' Biosimilar of Neupogen Gets Favorable Opinion - Analyst Blog
1/8/2015 1:50:00 PM - Investopedia


Pfizer Boosts Vaccine Pipeline with Redvax Acquisition - Analyst Blog
1/7/2015 5:25:00 AM - Investopedia


Roche Collaborates with 23andMe for Parkinson's Disease - Analyst Blog
1/7/2015 4:00:00 AM - Investopedia


Hedge Fund Clustering
1/6/2015 12:25:00 PM - Seeking Alpha


Pharmacyclics Reports Encouraging Data on Cancer Drug - Analyst Blog
1/6/2015 5:45:00 AM - Investopedia


Salix Pharmaceuticals CEO Logan Plans to Retire -- Update
1/5/2015 7:39:00 PM - Dow Jones Business News


Salix Pharmaceuticals CEO Logan Plans to Retire
1/5/2015 5:12:00 PM - Dow Jones Business News


Merger Arbitrage Mondays - January 5, 2015
1/5/2015 6:34:00 AM - Seeking Alpha


To Last, M&A Boom Needs to Broaden
1/1/2015 11:58:00 AM - Dow Jones Business News


Hedge Funds Stumble Over M&A in 2014
12/30/2014 3:31:00 PM - Dow Jones Business News


Teva's Granix Label Expanded to Include Self-Administration - Analyst Blog
12/30/2014 5:25:00 AM - Investopedia